BridgeMD
New treatment option for Hip Replacement Surgery
Official title OPPOSED (anteriOr hiP arthroPlasty regiOnal aneSthEsia stuDy) Study
ClinicalTrials.gov ID: NCT07017192
What this study is testing
- What it's testing
- Main indications for total hip arthroplasty (THA) are degenerative osteoarthritis of the coxofemoral joint, osteonecrosis of the hip, congenital disorders such as dysplasia and inflammatory arthritis. More recently, surgery using the direct anterior approach is getting popularity: this method, in fact, granting a significant sparing of the hip muscles, is associated with favorable results compared to other techniques, such as a lower risk of dislocation, limitated damage to soft tissues with better recovery and early discharge.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 85
You may be able to join if
- Age \>=18 years and =\<85 years
- patients undergoing elective unilateral THA with direct anterior approach
- patients able to understand the purposes of the study and provide signed informed consent
You likely can't join if
- pregnancy
- Age \ 85 years
- revision or bilateral surgeries
- psychiatric pathology or cognitive deficits, mental retardation, inability to provide valid informed consent
- History of illicit drugs and/or alcohol abuse
- urgent/emergent surgery with admission to Intensive Care under sedation and mechanical ventilation or complications that do not allow evaluation
See the full eligibility criteria
- Age \>=18 years and =\<85 years
- patients undergoing elective unilateral THA with direct anterior approach
- patients able to understand the purposes of the study and provide signed informed consent
- pregnancy
- Age \ 85 years
- revision or bilateral surgeries
- psychiatric pathology or cognitive deficits, mental retardation, inability to provide valid informed consent
- History of illicit drugs and/or alcohol abuse
- urgent/emergent surgery with admission to Intensive Care under sedation and mechanical ventilation or complications that do not allow evaluation
- known allergy to the drugs used in the study
- refusal to provide informed consent
The study team makes the final eligibility decision.
Where it's taking place
- Torino, TO, Italy
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Torino, TO, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.